The U.S. Disease Epidemic and MAHA

Despite the huge amount of appropriated funds and the strenuous efforts of many individuals working in healthcare, Americans have increasingly suffered from a range of acute and chronic conditions over recent decades. As an influential member of the Trump administration, Robert F. Kennedy Jr. will have the opportunity to begin a reversal of this trend. He is developing plans to revamp the Federal agencies that regulate the medical and pharmaceutical industries.

Mr. Kennedy has presented incontrovertible data about the state of our health. He says the first step towards change is reforming policies and restoring compromised government oversight.   

It will take a concerted effort to convert a system that has allowed an array of degrading health conditions and an avalanche of human suffering. The statistics compiled by reliable scientific sources reveal details of this staggering crisis.

~ Six out of ten adults in America are living with a chronic illness. Seventy-four percent of American adults are overweight or obese. Rates of kidney disease and autoimmune conditions are going up. Cancer rates among young people are rising.

~ One-third of American teens are taking a prescription drug and nearly 30% are pre-diabetic. More than 18% of adolescents have nonalcoholic fatty liver disease. In 2020, 77% of young adults didn’t qualify for the military based on their health scores, forcing the military to lower its standards.

~ Health problems of young Americans begin at an early age even as they receive vaccines to protect them from illness. The CDC currently recommends at least 70 doses of 18 different vaccines from infancy until age eighteen, yet children have never had more acute and chronic ailments. These vaccination protocols urgently need re-evaluation.

The increasing use of prescription drugs by all Americans presents a dire warning. However, due to the unprecedented influence of lobbyists, elected representatives have allowed the pharmaceutical industry rampant freedom to sell questionable products.

Washington has not solved the problem of the revolving doors between Big Pharma and government regulators. This is the primary reason federal agencies are paralyzed by corporate interests and remain negligent in their protective roles. 

Keep reading